Michael Jefford

Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites

Zheng Liu, Jennifer H Martin, Winston Liauw, Sue-Anne Mclachlan, Emma Link, Anetta Matera, Michael Thompson, Michael Jefford, Rod J Hicks, Carleen Cullinane, Athena Hatzimihalis, Ian Campbell, Simone Crowley, Phillip J Beale, Christos S Karapetis, Timothy Price, Mathew E Burge, Michael Michael

Journal article  |  2021  |  EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

BACKGROUND: Body surface area (BSA)-based dosing of irinotecan (IR) does not account for its pharmacokinetic (PK) and pharmacodyna..

Cancer survivorship care and general practice: A qualitative study of roles of general practice team members in Australia

Jennifer Fox, Carla Thamm, Geoff Mitchell, Jon Emery, Joel Rhee, Nicolas H Hart, Patsy Yates, Michael Jefford, Bogda Koczwara, Elizabeth Halcomb, Raylene Steinhardt, Roslyn O'Reilly, Raymond J Chan

Journal article  |  2021  |  HEALTH & SOCIAL CARE IN THE COMMUNITY

Primary care providers, including general practice teams (GPTs), are well positioned within the community to integrate cancer surv..

Clinical characteristics and outcomes of patients with oligometastatic colorectal cancer treated with curative intent

Andrew Parsonson, Katharine Kline, Annette Tognela, Aflah Roohullah, Vanessa Wong, Sumitra Ananda, Rachel Wong, Michael Jefford, Jeanne Tie, Adnan Khattak, Prasad Cooray, Shehara Mendis, Jeremy Shapiro, Grace Gard, Julie Johns, Peter Gibbs, Stephanie Lim

Conference Proceedings  |  2021  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Optimal care for people affected by cancer

Michael Jefford

Journal article  |  2021  |  AUSTRALIAN JOURNAL OF GENERAL PRACTICE

Improving care and outcomes for cancer survivors: An Australian experience

Michael Jefford

Conference Proceedings  |  2021  |  ANNALS OF ONCOLOGY

Feasibility of implementing a pharmacist-led DPYD gene testing service for patients commencing 5-fluorouracil (5FU) or capecitabine.

Benjamin Lee, Sarah Glewis, Marliese Alexander, Danny Rischin, Prudence A Francis, Michael Jefford, Hui-Li Wong, Jeanne Tie, Michael Michael, Senthil Lingaratnam

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

e18644 Background: Polymorphisms in the DPYD gene, which encodes for dihydropyrimidine dehydrogenase (DPD), may impair DPD metabo..

Mapping geographical disparities in population-level patient-reported quality of life following prostate cancer management.

Kendrick Koo, Nathan Papa, Melanie Evans, Michael Jefford, Maarten J IJzerman, Jeremy Laurence Millar

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

e18531 Background: Prostate cancer patients generally have good survival outcomes, but some survivors have poor functional outcom..

How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi Study

Karolina Lisy, Lena Ly, Helana Kelly, Melanie Clode, Michael Jefford

Journal article  |  2021  |  CANCERS

This research sought to answer the question 'what quality criteria do survivorship experts consider to be important in achieving o..

Management of Cancer and Health After the Clinic Visit: A Call to Action for Self-Management in Cancer Care

Doris Howell, Deborah K Mayer, Richard Fielding, Manuela Eicher, Irma M Verdonck-de Leeuw, Christoffer Johansen, Enrique Soto-Perez-de-Celis, Claire Foster, Raymond Chan, Catherine M Alfano, Shawna Hudson, Michael Jefford, Wendy WT Lam, Victoria Loerzel, Gabriella Pravettoni, Elke Rammant, Lidia Schapira, Kevin D Stein, Bogda Koczwara

Journal article  |  2021  |  JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

Individuals with cancer and their families assume responsibility for management of cancer as an acute and chronic disease. Yet, ca..

Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapy

Julia Lai-Kwon, Sarah Heynemann, Jacinthe Flore, Haryana Dhillon, Mary Duffy, John Burke, Lisa Briggs, Lillian Leigh, Linda Mileshkin, Benjamin Solomon, David Ball, Renata Kokanovic, Michael Jefford

Journal article  |  2021  |  JOURNAL OF CANCER SURVIVORSHIP

PURPOSE: Immunotherapy (IT) and targeted therapy (TT) have improved survival for some patients with metastatic non-small cell lung..